MicroRNAs are involved in the regulation of tumor formation. A previous study suggested that miR‐10a promotes glioma cell migration and invasion. However, the effect of miR‐10a on the proliferation of glioma cells remains unknown. In this study, we demonstrated that miR‐10a promoted proliferation and reduced apoptosis in glioma cells by directly targeting the 3′‐UTR of myotubularin‐related protein 3 (MTMR3). miR‐10a enhanced, while MTMR3 weakened, the growth of glioma in vivo. Ectopic expression of MTMR3 neutralized the effect of miR‐10a on glioma. Furthermore, miR‐10a and MTMR3 regulated β‐catenin expression and genes downstream of the Wnt/β‐catenin signaling pathway, such as Bcl‐2, c‐myc, p‐c‐Jun, and cleaved caspase‐3, to affect the proliferation ability and apoptosis of glioma cells. In conclusion, our results indicated that miR‐10a regulated cell proliferation and apoptosis by directly targeting MTMR3 and could function as a prognostic factor for progression of glioma.
Background: Long noncoding RNAs (lncRNAs) are considered key players in the formation and development of tumors. Herein, Gene Expression Profiling Interactive Analysis (GEPIA) was employed as a bioinformatics technology. LINC02587 is differentially expressed in bladder urothelial cancer, glioblastoma, lung adenocarcinoma, lung SCC, melanoma, and other tumor tissue and cells. However, its impact on the emergence of glioma and its mechanism is remaining elusive. Methods: Some of the in vitro assays employed in this study were the CCK-8 / Annexin-V / Transwell assays, colony formation, and wound healing, together with Western blot (WB) evaluation. MSP / BSP assays were employed for assessing the CpG island’s methylation status in the LINC02587 promoter. Through transcriptome, ferroptosis-related experiments, and WB evaluation, it was confirmed that LINC02587 is correlated with the regulation of ferroptosis in tumor cells, and CoQ-Fsp1 is one of its regulatory pathways. Moreover, the underlined in-vitro results were further validated by in-vivo studies. Results: The current study shows that the promoter sequence of LINC02587 is regulated by methylation. The silencing of LINC02587 can inhibit cellular proliferative, migrative, and invasive properties, and induce ferroptosis within gliomas through the CoQ-FSP1 pathway. Conclusions: LINC02587 is likely to be a novel drug target in treating glioma.
1 July 2015 in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
To investigate the regulatory functions and molecular mechanisms of miR211 in hepatocellular carcinoma (HCC). Real-time reverse transcription-PCR was used to analyze the expression of miR-211 in 20 paired clinical specimens of HCC and adjacent noncancerous tissues.QGY7703 and HepG2 cells with stimulation or inhibition of miR-211 expression were used to evaluate the effects on malignant phenotypes with the transwell invasion assay. Candidate target genes of miR-211 were identified by bioinformatic screening and verified by the EGFP report assay, real-time PCR and western blotting. Moreover, the regulatory functions of miR-211 on the target genes were investigated by RNA interference and cell phenotype assays. miR-211 was up-regulated in HCC tissue specimens (t =6.26, P < 0.01).HCC cells overexpressing miR-211 showed greater invasive capacity than cells with inhibited expression (QGY-7703:t =12.59, P < 0.01; HepG2: t =17.82, P < 0.01). Estrogen receptor a (ESR1) was identified and validated as a target gene of miR-211; knockdown of ESR 1 promoted HCC invasive capacity (QGY-7703:t =8.97, P < 0.01; HepG2:t =29.31, P < 0.01). miR-211 promotes invasion of carcinoma cells by directly targeting ESR1.
2 June 2026 in Journal of Global Antimicrobial Resistance
Acinetobacter baumannii, has been increasingly reported in nosocomial settings worldwide. However, the molecular characteristics and evolution history of A. baumannii in Tianjin-area hospitals in China have not been elucidated. In this study, we conducted a seven-month molecular epidemiological investigation of 114 A. baumannii isolates in Tianjin, China. Whole-genome sequencing was used to determine genomic species, sequence types, antimicrobial resistance genes and Single-nucleotide polymorphism (SNP)-based phylogenetic analysis. The genetic environment was analyzed using Nanopore sequencing. Among the 114 A. baumannii strains tested, 89.5% exhibited resistance to carbapenems. Whole-genome sequencing revealed that SToxf2499 A. baumannii accounted for 82.4% (94/114) of the isolates and was phylogenetically identified as a branch of STpas2. Phylogenetic analysis indicated that the SToxf2499 A. baumannii strains had undergone clonal spread within the hospital. However, these isolates were only distantly related to SToxf2499 A. baumannii isolates from other regions of China. Importantly, nanopore sequencing indicates that SToxf2499 strains have evolved by acquiring an IS15D1 composite transposon. This acquired element harbored a multidrug-resistant gene cluster and exhibited a high degree of similarity and coverage with that of A. baumannii SToxf191 from South Korea. This study identifies and describes the first large-scale emergence of SToxf2499 A. baumannii in Tianjin, China. Our study highlights that the continuous dissemination of SToxf2499 A. baumannii and its acquisition of IS15D1 composite transposon constitute a serious threat to hospitalized patients.